Group One Trading’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,807
Closed -$59K 9127
2021
Q3
$59K Buy
1,807
+1,037
+135% +$38K ﹤0.01% 6422
2021
Q2
$32K Sell
770
-1,090
-59% -$55.8K ﹤0.01% 6930
2021
Q1
$122K Buy
1,860
+1,373
+282% +$95.8K ﹤0.01% 5474
2020
Q4
$32K Sell
487
-1,450
-75% -$94.5K ﹤0.01% 5267
2020
Q3
$105K Buy
1,937
+1,684
+666% +$129K ﹤0.01% 4161
2020
Q2
$24K Buy
+253
New +$18.8K ﹤0.01% 4754
2018
Q3
Sell
-157
Closed -$22K 5792
2018
Q2
$22K Buy
157
+124
+376% +$17.1K ﹤0.01% 4333
2018
Q1
$5K Sell
33
-247
-88% -$33.6K ﹤0.01% 4524
2017
Q4
$34K Hold
280
﹤0.01% 3929
2017
Q3
$38K Buy
+280
New +$42.3K ﹤0.01% 3779
2016
Q3
Sell
-7
Closed -$1K 5043
2016
Q2
$1K Hold
7
﹤0.01% 4540
2016
Q1
$1K Buy
+7
New +$735 ﹤0.01% 4467
2013
Q4
Sell
-150
Closed -$17K 5640
2013
Q3
$17K Sell
150
-60
-29% -$6.81K ﹤0.01% 4266
2013
Q2
$24K Buy
+210
New +$25.7K ﹤0.01% 3978

Other funds holding SRGA

Group One Trading's SRGA Position: Q3 2023 in Review

Group One Trading sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 5,167 shares — an estimated $945 sold.

Group One Trading first reported a position in SRGA in Q3 2013 and held it in 19 quarters. The position peaked at $115K in Q4 2021. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

  • Group One Trading reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 5,167 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $945.
  • Group One Trading first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2013 and held it in 19 quarters.
  • Group One Trading's Surgalign Holdings, Inc. Common Stock position peaked at $115K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.